Welcome to the e-CCO Library!

DOP27: Disease activity patterns in the first 5 years after diagnosis in children with Crohn’s disease: a population-based study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Silvia Rotulo
Created: Friday, 14 July 2023, 2:22 PM
DOP27: Transanal minimally invasive surgery (TAMIS) – A noval approach for treatment of pouch failure
Year: 2020
Source: ECCO'20 Vienna
Authors: Elise Van Praag
Created: Tuesday, 23 June 2020, 5:40 PM
DOP28: Yield of surveillance colonoscopy in patients with Primary Sclerosing Cholangitis
Year: 2024
Source: ECCO'24 Stockholm
Authors: Van De Pol, Natasja
Created: Tuesday, 30 April 2024, 5:03 PM
DOP29: Single cell analysis of Crohn’s disease fistula; comparison of different locations
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Marte Becker
Created: Friday, 14 July 2023, 2:22 PM
DOP30: Cross-ethnic microbiome analyses identify shared and specific signals for Northern Indian IBD patients
Year: 2024
Source: ECCO'24 Stockholm
Authors: Gacesa, Ranko
Created: Tuesday, 30 April 2024, 5:03 PM
DOP31: Gut metabolomic and compositional signatures predict response to treatment with exclusive enteral nutrition in children with active Crohn’s disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Konstantinos Gerasimidis
Created: Friday, 14 July 2023, 2:22 PM
DOP32: Crohn’s disease stricture matrisome analysis reveals the anti-fibrotic activity of milk-fat globule-epidermal growth factor 8 (MFGE8)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Florian Rieder
Created: Friday, 14 July 2023, 2:22 PM
DOP33: Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease
Year: 2024
Source: ECCO'24 Stockholm
Authors: Bourgonje, Arno R.
Created: Tuesday, 30 April 2024, 5:03 PM
DOP33: Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn’s disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gianluca Matteoli
Created: Friday, 14 July 2023, 2:22 PM
DOP34: Deciphering immune-epithelial interactions in health and in Inflammatory Bowel Disease
Year: 2024
Source: ECCO'24 Stockholm
Authors: Neves, Joana F
Created: Tuesday, 30 April 2024, 5:03 PM
DOP34: Human MD2 deficiency - an inborn error of immunity predisposing to early onset Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yue Li
Created: Friday, 14 July 2023, 2:22 PM
DOP35: High-fat diet reduces gut microbiota-derived metabolite indole-acetic acid and aggravates colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mengfan Li
Created: Friday, 14 July 2023, 2:22 PM
DOP35: Spatial transcriptomics reveals cellular niches associated with histological inflammation in postoperative Crohn’s Disease
Year: 2024
Source: ECCO'24 Stockholm
Authors: Battat, Robert
Created: Tuesday, 30 April 2024, 5:03 PM
DOP36: Vedolizumab-treated IBD patients show an increased gut microbial diversity associated with a specific serum metabolic signature
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Laura Francesca Pisani
Created: Friday, 14 July 2023, 2:22 PM